Please use this identifier to cite or link to this item: https://www.um.edu.mt/library/oar/handle/123456789/12932
Full metadata record
DC FieldValueLanguage
dc.date.accessioned2016-10-13T08:36:57Z
dc.date.available2016-10-13T08:36:57Z
dc.date.issued2015
dc.identifier.urihttps://www.um.edu.mt/library/oar//handle/123456789/12932
dc.descriptionM.SC.MEDICAL PHYSICSen_GB
dc.description.abstractBackground: Di erentiated thyroid carcinoma patients undergo thyroidectomy, followed by radiodine ablation in hypothyroid or euthyroid state. Several attempts were made to predict the external dose rate, however, there is a lack of accuracy in predictions from existing models of dose rate decay. Objectives: Published models were compared to actual patient measurements to test their validity. A patient speci c model was developed to improve the accuracy in predicting the external dose rate on the seventh day post ingestion, based on in patient measurements. This study also tackled the e ect that recombinant thyroid stimulating hormone has on the e ective half life of I131 in patients. Finally, this project tested a di erent way to model the external dose rate, using the gamma variate t. Research Design: Matlab was used to compare actual patient measurements to published model. Mathematica was used to model patient measurements and check for accuracy and numerical stability of the model. Unpaired t-test was used to compare the e ective half lives of hypothyroid and euthyroid patients. Results: Published model overestimated the external dose rates by a mean value of 10 Sv/h. P values of 0.23 and 0.93 show that there is no signi cant di erence in e ective half life between hypothyroid and euthyroid patients. The model developed in this study under estimates the external dose rate measurement on the seventh day by an average of 0.5 muSv/h. Gamma variate has slightly better accuracy than the other models. Conclusion: Published models overestimate the external dose rate measurements in ablation patients. The main causes are the inaccuracy in average e ective half lives in the model and the fact that the models are population speci c rather than patient speci c. Recommendations: Further to this study, one needs to include a higher number of external dose rate measurements to model the dose rate decay more accuratelyen_GB
dc.language.isoenen_GB
dc.rightsinfo:eu-repo/semantics/restrictedAccessen_GB
dc.subjectThyroid gland -- Diseasesen_GB
dc.subjectThyroid gland -- Canceren_GB
dc.subjectIodine -- Isotopesen_GB
dc.titlePredictive modelling of external dose rate from radionuclide therapy patients following discharge from hospitalen_GB
dc.typemasterThesisen_GB
dc.rights.holderThe copyright of this thesis/dissertation belongs to the author. The author’s rights in respect of this work are as defined by the Copyright Act (Chapter 415) of the Laws of Malta or as modified by any successive legislation. Users may access this full-text thesis/dissertation and can make use of the information contained in accordance with the Copyright Act provided that the author must be properly acknowledged. Further distribution or reproduction in any format is prohibited without the prior permission of the copyright holder.en_GB
dc.publisher.institutionUniversity of Maltaen_GB
dc.publisher.departmentFaculty of Health Sciences. Department of Medical Physicsen_GB
dc.description.reviewedN/Aen_GB
dc.contributor.creatorAgius, Sam
Appears in Collections:Dissertations - FacHSc - 2015
Dissertations - FacHScMP - 2015

Files in This Item:
File Description SizeFormat 
15MSMP01.pdf
  Restricted Access
4.5 MBAdobe PDFView/Open Request a copy


Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.